Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sensitivity, Threshold, Tolerance and Pain Recognition in Schizophrenia Patients and Their Relatives

NCT05345548 is registered in ClinicalTrials.gov with HaEmek Medical Center, Israel as lead sponsor.

NCT NCT05345548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05345548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sensitivity, Threshold, Tolerance and Pain Recognition in Schizophrenia Patients and Their Relatives
Lead sponsor
HaEmek Medical Center, Israel
Phase
Not applicable
Overall status
Unknown status
Start date
August 29, 2019
Completion date
January 15, 2024
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain recognition, schizophrenia